X0306 4 2014-02-03 1 0001145404 CORNERSTONE THERAPEUTICS INC CRTX 0001529375 McBean Kenneth C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518 0 1 0 0 President Common Stock 2014-02-03 4 D 0 21955 9.50 D 0 D Common Stock 2014-02-03 4 D 0 61750 9.50 D 0 D Option to Purchase Common Stock (Right to Buy) 7.12 2014-02-03 4 D 0 18824 2.38 D 2021-09-06 Common Stock 18824 0 D Option to Purchase Common Stock (Right to Buy) 7.12 2014-02-03 4 D 0 56176 2.38 D 2021-09-06 Common Stock 56176 0 D Pursuant to the Agreement and Plan of Merger (the "Agreement") by and among Chiesi Farmaceutici S.p.A., Chiesi U.S. Corporation, and Cornerstone Therapeutics Inc., dated as of September 15, 2013, on the effective date of the merger contemplated by the Agreement (the "Merger"), each of these shares of common stock were automatically converted into the right to receive $9.50, without interest. Represents shares of restricted stock. Pursuant to the Merger, each restricted stock award outstanding at the effective time of the Merger was converted into the right to receive an amount in cash equal to the product of (i) $9.50 and (ii) the number of shares of Cornerstone Therapeutics Inc. common stock subject to such award. This option, which provided for vesting as to 25% of the original number of shares on the first anniversary of the grant date and as to an additional 2.09% of the original number of shares at the end of each successive one-month period following the first anniversary of the grant date until the fourth anniversary of the grant date, was cancelled in the Merger in exchange for a cash payment equal to the product of (i) the excess of $9.50 over the exercise price per share of the option and (ii) the total number of shares underlying the option. /s/ Amy Diebler, attorney-in-fact for Ken McBean pursuant to a power of attorney 2014-02-04